How long for semaglutide to work — what the evidence actually shows

What the trial data says about the first weeks

The STEP 1 trial, published in the New England Journal of Medicine, tracked weight changes week by week throughout a 68-week programme. The curve is telling: the steepest rate of loss came in the first 20 to 28 weeks, gradually flattening as participants approached a new, lower set-point. By week 12, many participants had already seen clinically significant reductions; by week 28, average losses were already well above 10% of starting weight.

That early arc reflects how the titration schedule works. Semaglutide starts at 0.25 mg, rising through 0.5 mg, 1.0 mg and 1.7 mg before reaching the 2.4 mg maintenance dose, each step roughly four weeks apart, guided by a prescriber. The lower doses are primarily there to reduce side effects; the therapeutic weight-loss effect strengthens as the dose climbs. Expecting dramatic change in week two is one of the most common misconceptions our prescribers encounter, and it's easy to understand, but patience in those early weeks is part of the process.

The NHS medicines page for semaglutide confirms that weight-loss effects build over time, and that some people see slower progress than others without that meaning the medicine isn't working. NICE's recommendation for semaglutide (TA875) includes a clinical checkpoint at six months on the maintenance dose: if less than 5% weight loss has occurred, continuing treatment is reviewed. That threshold underlines how gradual and cumulative the intended mechanism is.

Appetite shifts before the scales do

A question our prescribers hear regularly: "I don't feel like I'm losing weight yet, is it working?" The answer is almost always that appetite reduction arrives ahead of scale movement. Semaglutide is a GLP-1 receptor agonist; it mimics the gut hormone GLP-1, slowing gastric emptying and signalling fullness to the brain. Those effects can be perceptible within days to a couple of weeks of starting, often showing up as smaller portions, less interest in food between meals or a gentler appetite at the end of the day.

The weight loss that follows is a downstream result of that sustained appetite change, and it accumulates across months, not days. If you want a detailed breakdown of how long it takes for semaglutide to work, including what the clinical data shows at each stage of the journey, our dedicated guide walks through the timeline in full. Weighing at the same time each week, rather than daily, usually gives a clearer picture of how semaglutide is working over time.

If you're curious how the timeline compares to what Wegovy patients report in practice, our guide to how long Wegovy takes to work covers the patient-experience side alongside the clinical data.

Factors that shape how quickly semaglutide works for you

Trial averages describe populations; individual responses sit across a wide range. Several factors influence how quickly semaglutide takes effect in any one person.

Starting weight matters because people with a higher baseline BMI often see larger absolute losses in the earlier months, though percentage weight loss tends to converge at higher doses. Dose reached is significant too: participants in STEP 1 who tolerated the full 2.4 mg maintenance dose drove the headline average, those who stayed on lower doses for tolerability reasons typically lost less. Dietary pattern and activity level affect how much the appetite reduction translates into a calorie deficit. And biological factors including gut motility, individual GLP-1 sensitivity and metabolic rate introduce genuine variation that a trial average cannot capture.

The Wegovy treatment overview at nume covers how eligibility, dose and lifestyle all interact, and what to discuss with a prescriber before starting. There is also a separate, approved higher dose (7.2 mg) which the MHRA approved in early 2026 and which the trial data suggest narrows the gap with tirzepatide in average weight loss over 72 weeks; availability and suitability for any individual is a matter for clinical assessment.

For people wondering about the mechanics of the early titration period, the page covering how long it takes semaglutide to start working focuses specifically on those first few weeks, including what to expect at 0.25 mg and 0.5 mg. If you are also considering a lower-dose approach, our page on how long you can microdose semaglutide explains the evidence around extended lower-dose use and what a prescriber would need to assess. A note on private treatment costs, if that's relevant to your decision: the Wegovy cost page sets out what the market looks like and what a legitimate prescription service includes.

When to talk to your prescriber about progress

Semaglutide is a medicine; it works within a supervised clinical relationship, not in isolation. If you're on treatment and feel uncertain about your progress, that conversation belongs with your prescriber, not a forum. The formal checkpoint is the six-month review on the maintenance dose set out in NICE TA875, but any concerns about side effects, dose tolerance or the pace of results are worth raising sooner.

Signs that need prompt medical attention include severe or persistent stomach pain that radiates to the back (a potential indicator of pancreatitis, which the MHRA has flagged as a known infrequent but serious risk with GLP-1 medicines), significant nausea or vomiting that prevents eating or drinking, or any allergic reaction. These are covered clearly on the nume FAQs page, and our aftercare team is available seven days a week.

If you haven't started yet and want to understand whether semaglutide is the right route (or whether tirzepatide, the dual-agonist alternative, might suit you better) the free consultation at nume is the place to begin. A GPhC-registered Independent Prescriber reviews every consultation personally, the same day, and can talk through the timeline that's realistic for your situation.